Jenscare Scientific Co Ltd
Company Profile
Business description
Jenscare Scientific Co Ltd is engaged in the manufacturing and research and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure.
Contact
No. 777 Binhai 4th Road
Block 5, B Area, Hangzhou Bay New Area
Zhejiang Province
Ningbo
CHNT: +86 57463935666
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
174
Stocks News & Analysis
stocks
ASX healthcare giant remains well positioned despite share slump
stocks
Australian bank remains overvalued despite strong result
stocks
Chart of the Week: Soft earnings growth outlook for Australian banks
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,281.80 | 41.30 | -0.44% |
| CAC 40 | 8,402.13 | 88.89 | 1.07% |
| DAX 40 | 25,168.25 | 312.10 | 1.26% |
| Dow JONES (US) | 50,331.83 | 210.43 | 0.42% |
| FTSE 100 | 10,463.84 | 8.27 | -0.08% |
| HKSE | 27,032.54 | 233.84 | -0.86% |
| NASDAQ | 23,003.88 | 62.59 | -0.27% |
| Nikkei 225 | 57,639.84 | 10.70 | -0.02% |
| NZX 50 Index | 13,531.48 | 24.20 | 0.18% |
| S&P 500 | 6,948.28 | 6.81 | 0.10% |
| S&P/ASX 200 | 9,043.50 | 18.50 | -0.20% |
| SSE Composite Index | 4,134.02 | 2.03 | 0.05% |